Creatine Use and Muscle Stretching in Peripheral Artery Disease

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-12

Study Completion Date

2022-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To utilize near-infrared spectroscopy to investigate if the research device, which induces muscle stretching, and creatine loading impact submaximal exercise performance in aged and PAD patients. Near-infrared spectroscopy (NIRS)-derived tissue oxygenation responses will be obtained during device placement (muscle stretch) and during a walking test (i.e., six-minute walk test). Muscle oxygenation at rest and during device placement will be assessed with Magnetic Resonance Imaging. It is hypothesized that the stretching protocol will improve both NIRS-derived tissue oxygenation and magnetic resonance-derived muscle oxygenation and that creatine supplementation will further improve phosphorus metabolite muscle performance. All patients will undergo either 4 weeks of stretch training with- or- without creatine supplementation according to previously defined creatine guidelines.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening

NCT05710757

Proximal Muscle Strength Proximal Muscle Lengthening

ACTIVE_NOT_RECRUITING NA

A Study to Evaluate Breathing Muscle Training in Cardiac Rehab

NCT04984473

Healthy Heart Failure

RECRUITING NA

Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and Women

NCT03888040

Aging

RECRUITING NA

Blood Flow Reserve: Effects After Training With Heavy Inspiratory Exercises

NCT05632614

Coronary Artery Disease

ACTIVE_NOT_RECRUITING NA

The Effects of Lower Extremity Blood Flow Restriction Training on Power, and Muscle Size.

NCT03983070

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lower extremity peripheral artery disease (PAD) has been estimated to impact nearly 8.5 million U.S. adults above the age of 40, significantly increasing the rate of morbidity and mortality with concomitant decreases in quality of life. These patients are often given medical therapy (e.g., statins, antiplatelet, anticoagulants) and are also recommended to begin structured exercise programs. However, the limb ischemia that occurs during physical activity in these patients often limits exercise tolerance. A previous study by Bauer and colleagues showed that impaired muscle metabolism is a major contributor to functional limitations in PAD patients. These data are important in that they show alterations in blood flow and metabolic machinery likely impact exercise tolerance. As such, the development of tolerable countermeasures to improve limb blood flow and muscle energetics may increase adherence to exercise therapy and improve health outcomes in PAD patients. Previous work by the investigators has shown that daily muscle stretching, achieved via 30-minutes of ankle dorsiflexion, significantly improved soleus muscle function and muscle blood flow during exercise in a rat model of aging . In a follow-up study, the investigators have also shown that this model improves vascular function and walking function in PAD patients. As noted above, muscle energetics are delayed in PAD patients, so improving the rest-to-exercise transition with creatine supplementation may help PAD patients sustain exercise longer. The investigators are now testing to see if an added supplement can further improve the effects of muscle stretching in PAD patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Arterial Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Randomized, single-blind research design.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Creatine monohydrate

Creatine Monohydrate will be given at a 5 day loading period (10g/day) followed by a maintenance phase (5 g/day). The objectives of the current trial are to investigate if creatine supplementation plus muscle stretching improves 6-minute walking distance and muscle oxygenation in patients with peripheral artery disease.

Group Type EXPERIMENTAL

Creatine monohydrate

Intervention Type DRUG

Creatine monohydrate will be used in combination with muscle stretching.

Cellulose

These participants will consume a fiber supplement in place of creatine monohydrate at a matched dose with muscle stretching.

Group Type PLACEBO_COMPARATOR

Cellulose

Intervention Type DIETARY_SUPPLEMENT

Cellulose will be used in combination with muscle stretching.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Creatine monohydrate

Creatine monohydrate will be used in combination with muscle stretching.

Intervention Type DRUG

Cellulose

Cellulose will be used in combination with muscle stretching.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Ankle-brachial index (ABI) of 0.90 or less in either leg or clinical diagnosis by a medical doctor (PAD group only)
2. Stable condition for at least 3 months (PAD group only)

Exclusion Criteria

1. Habitual exercise or cardiovascular rehabilitation program during the past 3 months
2. Critical limb ischemia
3. Blow or above-knee amputation
4. Leg pain at rest
5. Major surgery or lower extremity revascularization in the last 3 months
6. Major medical illness treatment during the prior 12 months
7. Central neurological disease
8. Limited ankle or knee joint range of motion
9. Requirement of oxygen with activity or exercise
10. Heart failure
11. Atrial fibrillation
12. Wheelchair confinement or inability to walk
13. Cognitive disorder
14. Vasculitis problems including Takayasu's arteritis, Berger's disease, collagen disease or Reynaud's disease
15. Overt cardiovascular disease
16. Metabolic disease
17. Renal disease

Minimum Eligible Age

40 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes